ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 718630 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 718630; 2) Community: the network communities that were significantly associated with the response to NSC 718630; 3) Molecule: the relationships between components within communities and NSC 718630; 4) MDR: the compounds that were significantly associated with the NSC 718630.

NSC Compound Enrichment Correlation
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.022188614181866 0.40296293
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.022188614181866 0.3899193
NSC 267713 Digitoxigenin glycoside 0.022188614181866 0.42634148
NSC 281818 Ethanol, 2,2'-[[3-methyl-4-[[[4-[2-(4-propoxyphenyl]-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) 0.022188614181866 0.53559623
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.022188614181866 0.46127582
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.022188614181866 0.36021819
NSC 45236 Null 0.022188614181866 0.32043018
NSC 637411 Null 0.022188614181866 0.088932982
NSC 63878 Cytarabine Hydrochloride AZ 0.022188614181866 0.67524209
NSC 642947 Methanone, [3-(dibromomethyl)-6-chloroquinolin-2-yl] phenyl- 0.022188614181866 0.081982697
Total:75  Current:39    [First] [Prev] [Next] [Last]